Preterm Birth And PROM Testing Market

Industry Outlook

The preterm birth and PROM testing market is set to reach from US$ 996.3 Mn in 2017 to US$ 1,201.2 Mn by 2026 representing slow growth at a compounded annual growth rate (CAGR) of 2.1% during the forecast period from 2018 to 2026. As per the research findings of the World Health Organization (WHO), 15 million babies are born annually before the completion of 37 weeks of normal pregnancy. As a result, approximately 1 million children die annually due to complications associated with preterm births.

Excellent diagnostic accuracy and sensitivity will increase the popularity of biomarkers as PROM testing kits.

Physicians investigate preliminary symptoms such as vaginal bleeding, vaginal discharge, pelvic pressure, etc., to confirm preterm birth complications. Pelvic examination is the first line of diagnostic approach, which is performed several times to study the contraction and changes of the cervix. If the cervix begins to soften, dilate and become thin before 37 weeks of pregnancy, the patient is diagnosed with preterm labor. Biomarkers such as the Alpha-fetoprotein test (AFT), insulin-like growth factor binding protein-1 (IGFBP-1), placental alpha macroglobulin-1 (PAMG-1), etc., are gaining tremendous attention in the last decade. Excellent diagnostic accuracy and sensitivity increase the popularity of biomarkers as PROM testing kits.

Rising incidence of premature births and increasing maternal health awareness drive the market growth in North America region.

In the present scenario, North America is leading the regional segment for the preterm birth and PROM testing market with a share of 36%. Annually 3.9 million babies are born in North America, of which 12.0% are born prematurely. The rising incidence of premature births and increasing maternal health awareness drive market growth in the North American region. The existence of major players such as Abbott Laboratories, CooperSurgical, Inc., Qiagen, Inc., Hologic, Inc., etc., further propels the market growth in the North American region. Europe is the second largest market, with a share of 28% on account of the supportive regulatory environment provided by the European Medical Agency (EMA) for PROM testing kits and the establishment of well-developed healthcare infrastructure. The Asia Pacific currently holds a 15% market share and will be showcasing rapid growth in the near future due to increasing pregnancy complications and proactive government initiatives to provide optimum maternal care.

Historical & Forecast Period

This research report presents the analysis of each segment from 2016 to 2026, considering 2017 as the base year for the research. In addition, compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The market is segmented by test type and by geography.

ATTRIBUTEDETAILS

•  Research Period   2017-2027
•  The base Year 2018
•  Forecast Period   2019-2027
•  Historical Year   2017
•  Unit   USD Million

Segmentation  By Test Type (2016–2026; US$ Mn)

• Pelvic Exam
• Ferning Test
• Nitrazine Test
• Pooling Test
• Ultrasound Test
• Uterine Monitoring Test
• Biomarkers

 Geography Segment (2016–2026; US$ Mn)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • France
  • UK.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • South-east Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

Biopharmaceutical companies specializing in manufacturing preterm birth and PROM testing kits are Abbott Laboratories, Inc., Biosynex, Clinical Innovations, LLC, CooperSurgical, Inc., Hologic, Inc., I.Q. Medixbiochemica, NX Prenatal, Inc., Qiagen N.V., and Sera Prognostics, Inc.

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Test Types
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Preterm Birth and PROM Testing Market Portraiture
2.2. Global Preterm Birth and PROM Testing Market, by Test Type, 2017 (US$ Mn)
2.3. Global Preterm Birth and PROM Testing Market, by Geography, 2017 (US$ Mn)

Chapter 3. Preterm Birth and PROM Testing Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Preterm Birth and PROM Testing Market, by Key Players, 2017

Chapter 4. Global Preterm Birth and PROM Testing Market, by Test Type
4.1. Overview
4.2. Pelvic Exam
4.3. Ferning Test
4.4. Nitrazine Test
4.5. Pooling Test
4.6. Ultrasound Test
4.7. Uterine Monitoring Test
4.8. Biomarkers

Chapter 5. Global Preterm Birth and PROM Testing Market, by Geography
5.1. Overview
5.2. North America Preterm Birth and PROM Testing Market Analysis, 2016 – 2026
5.2.1. North America Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
5.2.2. North America Preterm Birth and PROM Testing Market, by Country, 2016 – 2026 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe Preterm Birth and PROM Testing Market Analysis, 2016 – 2026
5.3.1. Europe Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
5.3.2. Europe Preterm Birth and PROM Testing Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific Preterm Birth and PROM Testing Market Analysis, 2016 – 2026
5.4.1. Asia Pacific Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
5.4.2. Asia Pacific Preterm Birth and PROM Testing Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of Asia Pacific
5.5. Latin America Preterm Birth and PROM Testing Market Analysis, 2016 – 2026
5.5.1. Latin America Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
5.5.2. Latin America Preterm Birth and PROM Testing Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa Preterm Birth and PROM Testing Market Analysis, 2016 – 2026
5.6.1. MEA Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
5.6.2. MEA Preterm Birth and PROM Testing Market, by Region, 2016 – 2026 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA

Chapter 6. Company Profiles
6.1. Abbott Laboratories, Inc.
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. News Coverage
6.2. Biosynex
6.3. Clinical Innovations, LLC
6.4. CooperSurgical, Inc.
6.5. Hologic, Inc.
6.6. IQ Products.
6.7. Medixbiochemica
6.8. NX Prenatal, Inc.
6.9. Qiagen N.V.
6.10. Sera Prognostics, Inc.

List of Figures

FIG. 1 : Preterm Birth and PROM Testing Market: Research Methodology
FIG. 2 : Preterm Birth and PROM Testing: Market Segmentation
FIG. 3 : Global Preterm Birth and PROM Testing Market, by Test Type, 2017 (US$ Mn)
FIG. 4 : Global Preterm Birth and PROM Testing Market, by Geography, 2017 (US$ Mn)
FIG. 5 : Attractive Investment Proposition: by Geography, 2017
FIG. 6 : Competitive Analysis: Global Preterm Birth and PROM Testing Market, by Key Players, 2017
FIG. 7 : Global Pelvic Exam Market for Preterm Birth and PROM Testing, 2016 – 2026 (US$ Mn)
FIG. 8 : Global Ferning Test Market for Preterm Birth and PROM Testing, 2016 – 2026 (US$ Mn)
FIG. 9 : Global Nitrazine Test Market for Preterm Birth and PROM Testing, 2016 – 2026 (US$ Mn)
FIG. 10 : Global Pooling Test Market for Preterm Birth and PROM Testing, 2016 – 2026 (US$ Mn)
FIG. 11 : Global Ultrasound Test Market for Preterm Birth and PROM Testing, 2016 – 2026 (US$ Mn)
FIG. 12 : Global Uterine Monitoring Test Market for Preterm Birth and PROM Testing, 2016 – 2026 (US$ Mn)
FIG. 13 : Global Biomarkers Test Market for Preterm Birth and PROM Testing, 2016 – 2026 (US$ Mn)
FIG. 14 : U.S. Preterm Birth and PROM Testing Market, 2016 – 2026 (US$ Mn)
FIG. 15 : Canada Preterm Birth and PROM Testing Market, 2016 – 2026 (US$ Mn)
FIG. 16 : U.K. Preterm Birth and PROM Testing Market, 2016 – 2026 (US$ Mn)
FIG. 17 : Germany Preterm Birth and PROM Testing Market, 2016 – 2026 (US$ Mn)
FIG. 18 : Rest of Europe Preterm Birth and PROM Testing Market, 2016 – 2026 (US$ Mn)
FIG. 19 : China Preterm Birth and PROM Testing Market, 2016 – 2026 (US$ Mn)
FIG. 20 : Japan Preterm Birth and PROM Testing Market, 2016 – 2026 (US$ Mn)
FIG. 21 : Rest of Asia Pacific Preterm Birth and PROM Testing Market, 2016 – 2026 (US$ Mn)
FIG. 22 : Brazil Preterm Birth and PROM Testing Market, 2016 – 2026 (US$ Mn)
FIG. 23 : Mexico Preterm Birth and PROM Testing Market, 2016 – 2026 (US$ Mn)
FIG. 24 : Rest of Latin America Preterm Birth and PROM Testing Market, 2016 – 2026 (US$ Mn)
FIG. 25 : GCC Preterm Birth and PROM Testing Market, 2016 – 2026 (US$ Mn)
FIG. 26 : Rest of Middle East and Africa Preterm Birth and PROM Testing Market, 2016 – 2026 (US$ Mn)

List of Tables

TABLE 1 : Global Preterm Birth and PROM Testing Market Portraiture
TABLE 2 : Global Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
TABLE 3 : Global Preterm Birth and PROM Testing Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 4 : North America Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
TABLE 5 : North America Preterm Birth and PROM Testing Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 6 : Europe Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
TABLE 7 : Europe Preterm Birth and PROM Testing Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 8 : Asia Pacific Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
TABLE 9 : Asia Pacific Preterm Birth and PROM Testing Market, by Country/Region, 2015 – 2025 (US$ Mn)
TABLE 10 : Latin America Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
TABLE 11 : Latin America Preterm Birth and PROM Testing Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 12 : Middle East and Africa Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
TABLE 13 : Middle East and Africa Preterm Birth and PROM Testing Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 14 : Abbott Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 15 : Biosynex: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 16 : Clinical Innovations, LLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 17 : CooperSurgical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 18 : Hologic, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 19 : IQ Products: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 20 : Medixbiochemica: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 : NX Prenatal, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 : Qiagen N.V.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 : Sera Prognostics, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)